WEREWOLF THERAPEUTICS INC HOWL
COM · Common Stock · CUSIP 95075A107
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($148.0k this quarter). Holder counts are more reliable. Shares outstanding: 27.6m as of 2021-06-04, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $17.43.
Biggest buyers
| RA CAPITAL MANAGEMENT, L.P. | New | +4.3m |
| MPM ASSET MANAGEMENT LLC | New | +4.3m |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New | +2.6m |
| MPM BIOIMPACT LLC | New | +2.4m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New | +1.0m |
| SPHERA FUNDS MANAGEMENT LTD. | New | +706.3k |
| Avidity Partners Management LP | New | +650.3k |
| Soleus Capital Management, L.P. | New | +563.4k |
| PFM Health Sciences, LP | New | +400.0k |
| BlackRock Inc. | New | +365.9k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| MOLL PETER 13G · exempt (held before listing) new · filed 2026-09-21 | 5.2% |
Fell to 5% or below in the last year: RA CAPITAL MANAGEMENT, L.P. (4.1%, 2026-07-02), MPM BioVentures 2014, L.P. (3.8%, 2026-05-12), Longwood Fund III, L.P. (3.5%, 2026-02-11)
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2019 | 0 | — | 0 | — | — |
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 4 | $45.4m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-06-16 | RA Capital Healthcare Fund LP +3 Director · See footnotes | Bought | $124.1k9.3k shares |
| 2021-06-15 | RA Capital Healthcare Fund LP +3 Director · See footnotes | Bought | $103.1k8.0k shares |
| 2021-06-14 | RA Capital Healthcare Fund LP +3 Director · See footnotes | Bought | $3.9m306.1k shares |
| 2021-05-04 | RA Capital Healthcare Fund LP +3 Director · See footnotes | Bought | $27.4m1.7m shares |
| 2021-05-04 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) +3 10% owner · Through Deerfield Partners, L.P. | Bought | $12.8m800.0k shares |
| 2021-05-04 | SPHERA FUNDS MANAGEMENT LTD. +2 10% owner · See footnote | Bought | $7.6m475.0k shares |
| 2021-05-04 | Arkin Moshe +2 10% owner · See footnote | Bought | $6.4m400.0k shares |
| 2021-05-04 | Lazarus Alon Director · See footnote | Bought | $6.4m400.0k shares |
| 2021-05-04 | Taiho Ventures LLC 10% owner | Bought | $5.0m312.5k shares |
| 2021-05-04 | Asanuma Sakae Director · See footnote | Bought | $5.0m312.5k shares |
| 2021-05-04 | Longwood Fund III, L.P. +1 10% owner · See footnote | Bought | $4.0m250.0k shares |
| 2021-05-04 | GADICKE ANSBERT +6 10% owner · See Footnote | Bought | $3.9m245.0k shares |
| 2021-05-04 | EVNIN LUKE Director · See Footnote | Bought | $2.4m150.8k shares |
| 2021-05-04 | Foley Todd +5 10% owner · See Footnote | Bought | $2.0m125.8k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 1.20% of their portfolio | 4.3m $74.8m | New |
| MPM ASSET MANAGEMENT LLC 13.89% of their portfolio | 4.3m $74.7m | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.79% of their portfolio | 2.6m $44.5m | New |
| MPM BIOIMPACT LLC 6.84% of their portfolio | 2.4m $41.6m | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 1.0m $17.4m | New |
| SPHERA FUNDS MANAGEMENT LTD. 1.09% of their portfolio | 706.3k $12.0m | New |
| Avidity Partners Management LP 0.31% of their portfolio | 650.3k $11.3m | New |
| DC Funds, LP 48.81% of their portfolio | 589.1k $10.3m | First filing |
| Soleus Capital Management, L.P. 1.51% of their portfolio | 563.4k $9.8m | New |
| PFM Health Sciences, LP 0.22% of their portfolio | 400.0k $7.0m | New |
| BlackRock Inc. 0.00% of their portfolio | 365.9k $6.4m | New |
| FMR LLC 0.00% of their portfolio | 315.0k $5.5m | New |
| Nicholas Investment Partners, LP 0.32% of their portfolio | 294.7k $5.1m | New |
| PLATINUM INVESTMENT MANAGEMENT LTD 0.08% of their portfolio | 206.9k $3.6m | New |
| Alyeska Investment Group, L.P. 0.04% of their portfolio | 206.2k $3.6m | Not comparable |
| Migdal Insurance & Financial Holdings Ltd. 0.03% of their portfolio | 187.5k $3.3m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 173.1k $3.0m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 108.2k $1.9m | New |
| CAAS CAPITAL MANAGEMENT LP 0.09% of their portfolio | 100.0k $1.7m | New |
| STATE STREET CORP 0.00% of their portfolio | 78.2k $1.4m | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 75.8k $1.3m | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 37.4k $653.0k | New |
| Aristides Capital LLC 0.34% of their portfolio | 25.6k $446.0k | New |
| Bank of New York Mellon Corp 0.00% of their portfolio | 22.2k $387.0k | New |
| Evercore Wealth Management, LLC 0.01% of their portfolio | 21.5k $375.0k | New |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 16.0k $280.0k | New |
| Arena Capital Advisors, LLC- CA 0.02% of their portfolio | 15.0k $261.0k | New |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 13.0k $227.0k | New |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 12.0k $209.0k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 11.3k $197.0k | New |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 10.5k $183.0k | New |
| CAPSTONE INVESTMENT ADVISORS, LLC 0.00% of their portfolio | 10.0k $174.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 9.4k $163.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.5k $78.0k | New |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 4.2k $74.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 2.0k $35.0k | New |
| STRS OHIO 0.00% of their portfolio | 1.8k $31.0k | New |
| UBS Group AG 0.00% of their portfolio | 1.0k $17.0k | New |
| Legal & General Group Plc 0.00% of their portfolio | 736 $13.0k | New |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 593 $10.0k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 519 $9.0k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 487 $8.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 267 $5.0k | New |
| Financial Perspectives, Inc 0.00% of their portfolio | 250 $4.4k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 52 $1.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |